Compliance with safe practices for preparing parenteral nutrition formulations

Brian C. O'Neal, Philip J Schneider, Craig A. Pedersen, Jay M. Mirtallo

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Abstract: Compliance with the guidelines of the National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition (NAG) was studied. A questionnaire based on the NAG guidelines was developed to identify common practices used in the preparation of parenteral nutrition formulations in a variety of health care settings. The questionnaire was mailed in January 2000 to a national sample of 1445 pharmacists. There were a total of 633 usable responses, for a net response rate of 45.2% (based on 1400 deliverable surveys). Almost 80% of the respondents were employed in an urban setting, and 64.3% worked in hospitals. Relatively high compliance was reported for guidelines related to filtration (86.9% and 85,9%), verification of product stability and compatibility by a pharmacist or computer program (86.4%), evaluation of the aseptic technique of persons preparing sterile products (81.4%), and having a pharmacist assess formulations to determine whether the contents are within acceptable standard ranges (78.8%). Low compliance was reported for guidelines related to the inclusion of dosing weight on the label (15.4%), the use of amount per day as the unit of measure for labeling ingredients (26.1%), direct pharmacist-to-pharmacist communication about prescriptions when patients are transferred among health settings (33.4%), and daily in-process or end-product quality assurance testing of formulations. The NAG guidelines on parenteral nutrition formulations with which pharmacists' practice was most discrepant were the use of amount per day as the unit of measure for labeling ingredients, inclusion of the patient's dosing weight on the label, direct pharmacist-to-pharmacist communication when patients are transferred, and daily quality assurance testing.

Original languageEnglish (US)
Pages (from-to)264-269
Number of pages6
JournalAmerican Journal of Health-System Pharmacy
Volume59
Issue number3
StatePublished - Feb 1 2002
Externally publishedYes

Fingerprint

Parenteral Nutrition
Pharmacists
Guidelines
Compliance
Communication
Weights and Measures
Program Evaluation
Practice Guidelines
Prescriptions
Software
Delivery of Health Care
Surveys and Questionnaires
Health

Keywords

  • Administration
  • Communication
  • Compliance
  • Compounding
  • Data collection
  • Dosage
  • Incompatibilities
  • Labeling
  • Nutrition
  • Pharmacists
  • Pharmacy, institutional, hospital
  • Protocols
  • Quality assurance
  • Stability

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Leadership and Management

Cite this

Compliance with safe practices for preparing parenteral nutrition formulations. / O'Neal, Brian C.; Schneider, Philip J; Pedersen, Craig A.; Mirtallo, Jay M.

In: American Journal of Health-System Pharmacy, Vol. 59, No. 3, 01.02.2002, p. 264-269.

Research output: Contribution to journalArticle

O'Neal, Brian C. ; Schneider, Philip J ; Pedersen, Craig A. ; Mirtallo, Jay M. / Compliance with safe practices for preparing parenteral nutrition formulations. In: American Journal of Health-System Pharmacy. 2002 ; Vol. 59, No. 3. pp. 264-269.
@article{69b90788e0ec424b9b7a9d51746eed3e,
title = "Compliance with safe practices for preparing parenteral nutrition formulations",
abstract = "Abstract: Compliance with the guidelines of the National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition (NAG) was studied. A questionnaire based on the NAG guidelines was developed to identify common practices used in the preparation of parenteral nutrition formulations in a variety of health care settings. The questionnaire was mailed in January 2000 to a national sample of 1445 pharmacists. There were a total of 633 usable responses, for a net response rate of 45.2{\%} (based on 1400 deliverable surveys). Almost 80{\%} of the respondents were employed in an urban setting, and 64.3{\%} worked in hospitals. Relatively high compliance was reported for guidelines related to filtration (86.9{\%} and 85,9{\%}), verification of product stability and compatibility by a pharmacist or computer program (86.4{\%}), evaluation of the aseptic technique of persons preparing sterile products (81.4{\%}), and having a pharmacist assess formulations to determine whether the contents are within acceptable standard ranges (78.8{\%}). Low compliance was reported for guidelines related to the inclusion of dosing weight on the label (15.4{\%}), the use of amount per day as the unit of measure for labeling ingredients (26.1{\%}), direct pharmacist-to-pharmacist communication about prescriptions when patients are transferred among health settings (33.4{\%}), and daily in-process or end-product quality assurance testing of formulations. The NAG guidelines on parenteral nutrition formulations with which pharmacists' practice was most discrepant were the use of amount per day as the unit of measure for labeling ingredients, inclusion of the patient's dosing weight on the label, direct pharmacist-to-pharmacist communication when patients are transferred, and daily quality assurance testing.",
keywords = "Administration, Communication, Compliance, Compounding, Data collection, Dosage, Incompatibilities, Labeling, Nutrition, Pharmacists, Pharmacy, institutional, hospital, Protocols, Quality assurance, Stability",
author = "O'Neal, {Brian C.} and Schneider, {Philip J} and Pedersen, {Craig A.} and Mirtallo, {Jay M.}",
year = "2002",
month = "2",
day = "1",
language = "English (US)",
volume = "59",
pages = "264--269",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "3",

}

TY - JOUR

T1 - Compliance with safe practices for preparing parenteral nutrition formulations

AU - O'Neal, Brian C.

AU - Schneider, Philip J

AU - Pedersen, Craig A.

AU - Mirtallo, Jay M.

PY - 2002/2/1

Y1 - 2002/2/1

N2 - Abstract: Compliance with the guidelines of the National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition (NAG) was studied. A questionnaire based on the NAG guidelines was developed to identify common practices used in the preparation of parenteral nutrition formulations in a variety of health care settings. The questionnaire was mailed in January 2000 to a national sample of 1445 pharmacists. There were a total of 633 usable responses, for a net response rate of 45.2% (based on 1400 deliverable surveys). Almost 80% of the respondents were employed in an urban setting, and 64.3% worked in hospitals. Relatively high compliance was reported for guidelines related to filtration (86.9% and 85,9%), verification of product stability and compatibility by a pharmacist or computer program (86.4%), evaluation of the aseptic technique of persons preparing sterile products (81.4%), and having a pharmacist assess formulations to determine whether the contents are within acceptable standard ranges (78.8%). Low compliance was reported for guidelines related to the inclusion of dosing weight on the label (15.4%), the use of amount per day as the unit of measure for labeling ingredients (26.1%), direct pharmacist-to-pharmacist communication about prescriptions when patients are transferred among health settings (33.4%), and daily in-process or end-product quality assurance testing of formulations. The NAG guidelines on parenteral nutrition formulations with which pharmacists' practice was most discrepant were the use of amount per day as the unit of measure for labeling ingredients, inclusion of the patient's dosing weight on the label, direct pharmacist-to-pharmacist communication when patients are transferred, and daily quality assurance testing.

AB - Abstract: Compliance with the guidelines of the National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition (NAG) was studied. A questionnaire based on the NAG guidelines was developed to identify common practices used in the preparation of parenteral nutrition formulations in a variety of health care settings. The questionnaire was mailed in January 2000 to a national sample of 1445 pharmacists. There were a total of 633 usable responses, for a net response rate of 45.2% (based on 1400 deliverable surveys). Almost 80% of the respondents were employed in an urban setting, and 64.3% worked in hospitals. Relatively high compliance was reported for guidelines related to filtration (86.9% and 85,9%), verification of product stability and compatibility by a pharmacist or computer program (86.4%), evaluation of the aseptic technique of persons preparing sterile products (81.4%), and having a pharmacist assess formulations to determine whether the contents are within acceptable standard ranges (78.8%). Low compliance was reported for guidelines related to the inclusion of dosing weight on the label (15.4%), the use of amount per day as the unit of measure for labeling ingredients (26.1%), direct pharmacist-to-pharmacist communication about prescriptions when patients are transferred among health settings (33.4%), and daily in-process or end-product quality assurance testing of formulations. The NAG guidelines on parenteral nutrition formulations with which pharmacists' practice was most discrepant were the use of amount per day as the unit of measure for labeling ingredients, inclusion of the patient's dosing weight on the label, direct pharmacist-to-pharmacist communication when patients are transferred, and daily quality assurance testing.

KW - Administration

KW - Communication

KW - Compliance

KW - Compounding

KW - Data collection

KW - Dosage

KW - Incompatibilities

KW - Labeling

KW - Nutrition

KW - Pharmacists

KW - Pharmacy, institutional, hospital

KW - Protocols

KW - Quality assurance

KW - Stability

UR - http://www.scopus.com/inward/record.url?scp=0036468360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036468360&partnerID=8YFLogxK

M3 - Article

C2 - 11862638

AN - SCOPUS:0036468360

VL - 59

SP - 264

EP - 269

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 3

ER -